Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2025 11:15 ET | Source: Research and Markets

Fusion Proteins Industry to Nearly Double by the End of 2030: Insights Into Emerging Trends, Innovations, Leading Applications and Competitive Growth Strategies

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Fusion Proteins: Global Market" has been added to ResearchAndMarkets.com's offering.The global fusion proteins market is poised to expand...
August 13, 2025 08:01 ET | Source: Research and Markets

Cytokines Market Forecast Report 2025-2030 | Revenues to Hit $145.25 Billion by 2030 | Detailed Insights by Type, Production, Formulation, Application, Country and Company

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Cytokines Market by Type (Chemokines, Colony-Stimulating Factors, Interferons), Production Method (Natural Cytokines, Synthetic Cytokines),...
June 25, 2025 04:27 ET | Source: Research and Markets

Cytokine Detection Reagent Industry Report 2025 | Market Trends, Forecasts and Competitive Analysis 2019-2031 - Rising Demand from Immunotherapy, Diagnostics, and Emerging Healthcare Markets

Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "Cytokine Detection Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. ...
September 26, 2024 07:00 ET | Source: Mural Oncology, Inc.

Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress

Key data readouts for the company’s late-stage, potentially registrational trials of nemvaleukin are expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal...
July 31, 2024 07:00 ET | Source: Mural Oncology, Inc.

Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors

WALTHAM, Mass and DUBLIN, July 31, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine...
June 12, 2024 10:51 ET | Source: Research and Markets

Global Protein Expression Market Report 2024-2032

Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global Protein Expression Market Report by Product, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
May 23, 2024 17:00 ET | Source: Mural Oncology, Inc.

Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting

ARTISTRY-3 trial is being conducted to evaluate less frequent dosing of nemvaleukin alfa, Mural’s late-stage lead candidate Nemvaleukin demonstrated pharmacodynamic proof of mechanism in ARTISTRY-3...
May 14, 2024 07:00 ET | Source: Mural Oncology, Inc.

Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update

Mural Oncology reiterates cash runway projection into 4Q 2025, with sufficient capital to fund key clinical readouts.
April 09, 2024 16:00 ET | Source: Mural Oncology, Inc.

Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting

Mural Oncology, a clinical-stage immuno-oncology company, shared pre-clinical data from its Interleukin-18 (IL-18) and IL-12 programs at AACR today.
April 05, 2024 09:27 ET | Source: Research and Markets

Cancer Cachexia Global Strategic Research Report 2024: Market to Reach $3.5 Billion by 2030, Driven by Promising Treatment Options

Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cancer Cachexia Market to Reach...